| Previously Reported Financial Statement Tables |
The following table represents a summary of the impacts of the revision at December 31, 2023.
| | | | | | | | | | | | | |
| |
|
December 31, 2023
| |
| | |
|
December 31, 2023
| |
| |
|
As Previously Reported
| |
|
Revision Impacts
| |
|
As Revised
| |
| |
(In thousands)
|
|
ASSETS
|
| | | |
| | | |
| | | |
|
Receivables:
|
| | | |
| | | |
| | | |
|
Insurance premiums and other
|
| $ | 23,690 | |
| $ | (3,457 | ) |
| $ | 20,233 | |
|
Deferred income taxes, net
|
| | 15,682 | |
| | 726 | |
| | 16,408 | |
|
Total assets
|
| | 381,265 | |
| | (2,731 | ) |
| | 378,534 | |
| |
| | | |
| | | |
| | | |
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
| | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
| |
| | | |
| | | |
| | | |
|
Accounts payable and accrued expenses
|
| | 24,811 | |
| | (1,523 | ) |
| | 23,288 | |
|
Total liabilities
|
| | 273,990 | |
| | (1,523 | ) |
| | 272,467 | |
| |
| | | |
| | | |
| | | |
|
Shareholders’ equity:
|
| | | |
| | | |
| | | |
|
Retained earnings
|
| | 50,929 | |
| | (1,208 | ) |
| | 49,721 | |
|
Total shareholders’ equity
|
| | 107,275 | |
| | (1,208 | ) |
| | 106,067 | |
|
Total liabilities and shareholders’ equity
|
| $ | 381,265 | |
| $ | (2,731 | ) |
| $ | 378,534 | |
The following table represents a summary of the impacts of the revision for the Balance Sheet at December 31, 2024.
| |
| | | |
| | | |
| | | |
| |
December 31, 2024
|
| |
|
As Previously Reported
| |
|
Revision Impacts
| |
|
As Revised
| |
| |
(In thousands)
|
|
ASSETS
|
| | | |
| | | |
| | | |
|
Receivables:
|
| | | |
| | | |
| | | |
|
Insurance premiums
|
| $ | 27,458 | |
| $ | (5,580 | ) |
| $ | 21,878 | |
|
Deferred income taxes, net
|
| | 18,118 | |
| | 1,172 | |
| | 19,290 | |
|
Total assets
|
| | 393,428 | |
| | (4,408 | ) |
| | 389,020 | |
| |
| | | |
| | | |
| | | |
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
| | | |
| | | |
| | | |
|
Accounts payable and other accrued expenses
|
| | 30,948 | |
| | (2,923 | ) |
| | 28,025 | |
|
Total liabilities
|
| | 293,815 | |
| | (2,923 | ) |
| | 290,892 | |
| |
| | | |
| | | |
| | | |
|
Shareholders’ equity:
|
| | | |
| | | |
| | | |
|
Retained earnings
|
| | 45,854 | |
| | (1,485 | ) |
| | 44,369 | |
|
Total shareholders’ equity
|
| | 99,613 | |
| | (1,485 | ) |
| | 98,128 | |
|
Total liabilities and shareholders’ equity
|
| $ | 393,428 | |
| $ | (4,408 | ) |
| $ | 389,020 | |
The following table represents a summary of the impacts of the revision for the Statement of Operations for the year ended December 31, 2024.
| |
| | | |
| | | |
| | | |
| |
Year Ended December 31, 2024
|
| |
|
As Previously Reported
| |
|
Revision Impacts
| |
|
As Revised
| |
| |
(In thousands, except share and per share data)
|
|
Revenue:
|
| | | |
| | | |
| | | |
|
Insurance premiums, net
|
| $ | 178,731 | |
| $ | (351 | ) |
| $ | 178,380 | |
|
Total revenue
|
| | 188,227 | |
| | (351 | ) |
| | 187,876 | |
| |
| | | |
| | | |
| | | |
|
Loss before income taxes
|
| | (5,264 | ) |
| | (351 | ) |
| | (5,615 | ) |
|
Income tax benefit
|
| | (996 | ) |
| | (74 | ) |
| | (1,070 | ) |
|
Net loss
|
| | (4,268 | ) |
| | (277 | ) |
| | (4,545 | ) |
|
Net loss applicable to common shareholders
|
| $ | (4,667 | ) |
| $ | (277 | ) |
| $ | (4,944 | ) |
|
Earnings (loss) per common share (basic)
|
| $ | (0.23 | ) |
| $ | (0.02 | ) |
| $ | (0.25 | ) |
|
Earnings (loss) per common share (diluted)
|
| $ | (0.23 | ) |
| $ | (0.02 | ) |
| $ | (0.25 | ) |
The following table represents a summary of the impacts of the revision for the Statement of Comprehensive Income for the year ended December 31, 2024.
| |
| | | |
| | | |
| | | |
| |
Year Ended December 31, 2024
|
| |
|
As Previously Reported
| |
|
Revision Impacts
| |
|
As Revised
| |
| |
(In thousands)
|
|
Net loss
|
| $ | (4,268 | ) |
| $ | (277 | ) |
| $ | (4,545 | ) |
|
Other comprehensive gain (loss):
|
| | | |
| | | |
| | | |
|
Future policy benefit discount rate remeasurement gain (loss)
|
| | - | |
| | - | |
| | | |
|
Subtotal
|
| | (3,280 | ) |
| | | |
| | (3,280 | ) |
| |
| | | |
| | | |
| | | |
|
Related income tax effect
|
| | 689 | |
| | | |
| | 689 | |
|
Subtotal
|
| | 689 | |
| | | |
| | 689 | |
| |
| | | |
| | | |
| | | |
|
Total other comprehensive income, net of tax
|
| | (2,591 | ) |
| | - | |
| | (2,591 | ) |
|
Total comprehensive income
|
| $ | (6,859 | ) |
| $ | (277 | ) |
| $ | (7,136 | ) |
The following table represents a summary of the impacts of the revision for the Statement of Stockholders' Equity at December 31, 2024.
| |
| | | |
| | | |
| | | |
| |
Year Ended December 31, 2024
|
| |
|
As Previously Reported
| |
|
Revision Impacts
| |
|
As Revised
| |
|
(In thousands)
|
| | | |
| | | |
| | | |
|
Retained earnings:
|
| | | |
| | | |
| | | |
|
Balance, beginning of year
|
| $ | 50,929 | |
| $ | (1,208 | ) |
| $ | 49,721 | |
|
Net loss
|
| | (4,268 | ) |
| | (277 | ) |
| | (4,545 | ) |
|
Balance, end of year
|
| | 45,854 | |
| | (1,485 | ) |
| | 44,369 | |
| |
| | | |
| | | |
| | | |
|
Total shareholders’ equity
|
| $ | 99,613 | |
| $ | (1,485 | ) |
| $ | 98,128 | |
The following table represents a summary of the impacts of the revision for the Statement of Cash Flows for the year ended December 31, 2024.
| |
| | | |
| | | |
| | | |
| |
Year Ended December 31, 2024
|
| |
|
As Previously Reported
| |
|
Revision Impacts
| |
|
As Revised
| |
| |
(In thousands)
|
|
Cash flows from operating activities:
|
| | | |
| | | |
| | | |
|
Net loss
|
| $ | (4,268 | ) |
| $ | (277 | ) |
| $ | (4,545 | ) |
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
| | | |
| | | |
| | | |
|
Deferred income tax benefit
|
| | (1,747 | ) |
| | (2,380 | ) |
| | (4,127 | ) |
|
Increase in receivables, net
|
| | (5,581 | ) |
| | 5,580 | |
| | (1 | ) |
|
(Decrease) increase in accounts payable and accrued expenses
|
| | 6,137 | |
| | (2,922 | ) |
| | 3,215 | |
|
Net cash provided by operating activities
|
| $ | 4,800 | |
| $ | - | |
| $ | 4,800 | |
The following table presents the effects of the retrospective application of the adoption of the new LDTI accounting guidance to the Company's previously reported consolidated balance sheet:
| |
| | | |
| | | |
| | | |
| |
December 31, 2024
|
| |
| |
As Revised
| |
| |
LDTI Adoption Impacts
| |
| |
As Adjusted
| |
| |
(In thousands)
|
|
ASSETS
|
| | | |
| | | |
| | | |
|
Receivables:
|
| | | |
| | | |
| | | |
|
Reinsurance recoverables
|
| $ | 22,942 | |
| $ | (61 | ) |
| $ | 22,881 | |
|
Deferred income taxes, net
|
| | 19,290 | |
| | (3,320 | ) |
| | 15,970 | |
|
Deferred acquisition costs
|
| | 44,842 | |
| | (3,598 | ) |
| | 41,244 | |
|
Other assets
|
| | 11,828 | |
| | (2 | ) |
| | 11,826 | |
|
Total assets
|
| | 389,020 | |
| | (6,981 | ) |
| | 382,039 | |
| |
| | | |
| | | |
| | | |
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
| | | |
| | | |
| | | |
|
Insurance reserves and policyholder funds
|
| | | |
| | | |
| | | |
|
Future policy benefits
|
| | 98,464 | |
| | (21,583 | ) |
| | 76,881 | |
|
Unearned premiums
|
| | 31,178 | |
| | (2,333 | ) |
| | 28,845 | |
|
Other policy liabilities
|
| | 1,757 | |
| | 4,492 | |
| | 6,249 | |
|
Total insurance reserves and policyholder funds
|
| | 225,106 | |
| | (19,424 | ) |
| | 205,682 | |
|
Total liabilities
|
| | 290,892 | |
| | (19,424 | ) |
| | 271,468 | |
| |
| | | |
| | | |
| | | |
|
Shareholders’ equity:
|
| | | |
| | | |
| | | |
|
Retained earnings
|
| | 44,369 | |
| | (870 | ) |
| | 43,499 | |
|
Accumulated other comprehensive loss
|
| | (18,712 | ) |
| | 13,313 | |
| | (5,399 | ) |
|
Total shareholders’ equity
|
| | 98,128 | |
| | 12,443 | |
| | 110,571 | |
|
Total liabilities and shareholders’ equity
|
| $ | 389,020 | |
| $ | (6,981 | ) |
| $ | 382,039 | |
The following table presents the effects of the retrospective application of the adoption of the new LDTI accounting guidance to the Company's previously reported consolidated statement of operations:
| |
| | | |
| | | |
| | | |
| |
Year Ended December 31, 2024
|
| |
| |
As Revised
| |
| |
LDTI Adoption Impacts
| |
| |
As Adjusted
| |
| |
(In thousands, except share and per share data)
|
|
Revenue:
|
| | | |
| | | |
| | | |
| Insurance premiums, net |
| $ | 178,380 | |
| $ | (208 | ) (1) |
| $ | 178,588 | |
|
Total revenue
|
| | 187,876 | |
| | 206 | |
| | 188,082 | |
| |
| | | |
| | | |
| | | |
|
Benefits and expenses:
|
| | | |
| | | |
| | | |
|
Insurance benefits and losses incurred
|
| | 125,831 | |
| | (1,753 | ) |
| | 124,078 | |
|
Future policy benefits remeasurement (gain) loss
|
| | - | |
| | (2,334 | ) |
| | (2,334 | ) |
|
Commissions and underwriting expenses
|
| | 48,030 | |
| | 303 | |
| | 48,333 | |
|
Total benefits and expenses
|
| | 193,491 | |
| | (3,784 | ) |
| | 189,707 | |
| |
| | | |
| | | |
| | | |
|
Loss before income taxes
|
| | (5,615 | ) |
| | 3,990 | |
| | (1,625 | ) |
|
Income tax benefit
|
| | (1,070 | ) |
| | 838 | |
| | (232 | ) |
|
Net loss
|
| | (4,545 | ) |
| | 3,152 | |
| | (1,393 | ) |
|
Net loss applicable to common shareholders
|
| $ | (4,944 | ) |
| $ | 3,152 | |
| $ | (1,792 | ) |
|
Earnings (loss) per common share (basic)
|
| $ | (0.25 | ) |
| $ | 0.16 | |
| $ | (0.09 | ) |
|
Earnings (loss) per common share (diluted)
|
| $ | (0.25 | ) |
| $ | 0.16 | |
| $ | (0.09 | ) |
(1) Related to reclassification of group accident and health from long duration to short duration. The following table presents the effects of the retrospective application of the adoption of the new LDTI accounting guidance to the Company's previously reported consolidated statements of comprehensive income:
| |
| | | |
| | | |
| | | |
| |
Year Ended December 31, 2024
|
| |
| |
As Revised
| |
| |
LDTI Adoption Impacts
| |
| |
As Adjusted
| |
| |
(In thousands)
|
|
Net loss
|
| | (4,545 | ) |
| | 3,152 | |
| | (1,393 | ) |
|
Other comprehensive gain (loss):
|
| | | |
| | | |
| | | |
|
Future policy benefit discount rate remeasurement gain (loss)
|
| | - | |
| | 8,774 | |
| | 8,774 | |
|
Subtotal
|
| | (3,280 | ) |
| | 8,774 | |
| | 5,494 | |
| |
| | | |
| | | |
| | | |
|
Related income tax effect
|
| | 689 | |
| | (1,843 | ) |
| | (1,154 | ) |
|
Subtotal
|
| | 689 | |
| | (1,843 | ) |
| | (1,154 | ) |
| |
| | | |
| | | |
| | | |
|
Total other comprehensive income, net of tax
|
| | (2,591 | ) |
| | 6,931 | |
| | 4,340 | |
|
Total comprehensive income
|
| | (7,136 | ) |
| $ | 10,083 | |
| | 2,947 | |
The following table presents the effects of the retrospective application of the adoption of the new LDTI accounting guidance to the Company's previously reported consolidated statements of equity:
| |
| | | |
| | | |
| | | |
| |
Year Ended December 31, 2024
|
| |
| |
As Revised
| |
| |
LDTI Adoption Impacts
| |
| |
As Adjusted
| |
|
(In thousands)
|
| | | |
| | | |
| | | |
|
Retained earnings:
|
| | | |
| | | |
| | | |
|
Balance, beginning of year
|
| $ | 49,721 | |
| $ | (4,022 | ) |
| $ | 45,699 | |
| Net loss |
| | (4,545 | ) |
| | 3,152 | |
| | (1,393 | ) |
|
Balance, end of year
|
| | 44,369 | |
| | (870 | ) |
| | 43,499 | |
|
Accumulated other comprehensive loss:
|
| | | |
| | | |
| | | |
|
Balance, beginning of year
|
| | (16,121 | ) |
| | 6,382 | |
| | (9,739 | ) |
|
Other comprehensive income (loss), net of tax
|
| | (2,591 | ) |
| | 6,931 | |
| | 4,340 | |
|
Balance, end of year
|
| | (18,712 | ) |
| | 13,313 | |
| | (5,399 | ) |
| |
| | | |
| | | |
| | | |
|
Total shareholders’ equity
|
| $ | 98,128 | |
| $ | 12,443 | |
| $ | 110,571 | |
The following table presents the effects of the retrospective application of the adoption of the new LDTI accounting guidance to the Company's previously reported consolidated statements of cash flows:
| | | | | | | | | | | | | |
| |
Year Ended December 31, 2024
|
| |
| |
As Revised
| |
| |
LDTI Adoption Impacts
| |
| |
As Adjusted
| |
| |
(In thousands)
|
|
Cash flows from operating activities:
|
| | | |
| | | |
| | | |
|
Net loss
|
| | (4,545 | ) |
| $ | 3,152 | |
| | (1,393 | ) |
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
| | | |
| | | |
| | | |
|
Amortization of deferred acquisition costs
|
| | 16,645 | |
| | 1,906 | |
| | 18,551 | |
|
Acquisition costs deferred
|
| | (17,637 | ) |
| | (1,602 | ) |
| | (19,239 | ) |
|
Benefit provision for credit losses
|
| | (26 | ) |
| | 22 | |
| | (4 | ) |
|
Deferred income tax benefit
|
| | (4,127 | ) |
| | 837 | |
| | (3,290 | ) |
|
Increase in receivables, net
|
| | (1 | ) |
| | 2,889 | |
| | 2,888 | |
|
Increase in insurance reserves and policyholder funds
|
| | 12,684 | |
| | (7,204 | ) |
| | 5,480 | |
|
Net cash provided by operating activities
|
| $ | 4,800 | |
| $ | - | |
| $ | 4,800 | |
|